Monitor for any warrant exercise announcements or further dilutive offerings. The stock is likely to face continued selling pressure from the registered shares overhang given the company's precarious financial position.
Price Chart
Executive Summary
The SEC declared effective the S-1 registration statement filed on May 26, 2026, covering up to 7.64 million shares of common stock for resale by institutional investors. GeoVax remains a clinical-stage biotech with a going concern opinion and only ~$1.3M cash as of March 31, 2026, with no product revenue. The effectiveness removes the last barrier for warrant holders to sell shares, creating dilution overhang.
Key Facts
- Effectiveness date June 3, 2026 for S-1 file number 333-296214
- Up to 7.64 million shares registered for resale by institutional investors
- Company had ~$1.3M cash as of March 31, 2026 with going concern opinion
- No product revenue; clinical-stage biotech
Financial Impact
Potential dilution from up to 7.64M shares resold; company may receive up to ~$8.6M if warrants exercised for cash
Risk Factors
- Further dilution from additional offerings
- Cash burn accelerating without product revenue
- Going concern risk if cash runs out
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001874 |
| Document: 9999999995-26-001874-index.html | 9999999995-26-001874 |
| Document: 9999999995-26-001874.txt | 9999999995-26-001874 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $0.2032 | awaiting T+60 | — | $0.2012 (+0.98%) |
Sep 24, 2026 4w ago | EFFECT | $0.3603 | awaiting T+60 | — | $0.2012 (+44.16%) |
Jun 4, 2026 20w ago | EFFECT | $1.79 $0.7210 | ▲ +59.72% | ▲ +61.60% | $0.2012 (+88.76%) |
May 26, 2026 22w ago | S-1 | $3.49 $0.5947 | ▼ −82.96% | ▼ −85.68% | $0.2012 (−94.23%) |
May 19, 2026 23w ago | 8-K | $2.23 $0.7180 | ▲ +67.80% | ▲ +72.81% | $0.2012 (+90.98%) |
May 14, 2026 23w ago | 8-K | $1.23 $0.7700 | ▲ +37.40% | ▲ +41.91% | $0.2012 (+83.64%) |
May 7, 2026 24w ago | 8-K | $1.67 $0.7620 | ▲ +54.37% | ▲ +59.21% | $0.2012 (+87.95%) |
Apr 22, 2026 26w ago | EFFECT | $1.17 $0.9742 | ▼ −16.73% | ▼ −21.51% | $0.2012 (−82.80%) |
Apr 20, 2026 27w ago | EFFECT | $1.17 $1.01 | ▲ +13.68% | ▲ +20.45% | $0.2012 (+82.80%) |
Apr 15, 2026 27w ago | 8-K | $1.23 $1.11 | ▲ +9.76% | ▲ +16.80% | $0.2012 (+83.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers